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Diabetes is known as a multifactorial disease. The treatment of diabetes (Type II) is complicated due to the inherent patho-
physiological factors related to this disease. One of the complications of diabetes is post-prandial hyperglycemia (PPHG).
Glucosidase inhibitors, particularly α-amylase inhibitors are a class of compounds that helps in managing PPHG. Six ethno-
botanically known plants having antidiabetic property namely, Azadirachta indica Adr. Juss.; Murraya koenigii (L.) Sprengel;
Ocimum tenuﬂorum (L.) (syn: Sanctum); Syzygium cumini (L.) Skeels (syn: Eugenia jambolana); Linum usitatissimum (L.) and
Bougainvillea spectabilis were tested fortheir abilityto inhibitglucosidaseactivity. The chloroform,methanolandaqueous extracts
were prepared sequentially fromeither leaves orseeds of these plants.It wasobserved that thechloroformextract ofO. tenuﬂorum;
B. spectabilis; M. koenigii and S. cumini have signiﬁcant α-amylase inhibitory property. Plants extracts were further tested against
murine pancreatic, liver and small intestinal crude enzyme preparations for glucosidase inhibitory activity. The three extracts of
O. tenuﬂorum and chloroform extract of M. koenigi showed good inhibition of murine pancreatic and intestinal glucosidases as
compared with acarbose, a known glucosidase inhibitor.
1.Introduction
Diabetes is deﬁned as a state in which homeostasis of
carbohydrate and lipid metabolism is improperly regulated
by the pancreatic hormone, insulin; resulting in an increased
blood glucose level. Diabetes is a progressive disease and
is one of the major killers in recent times. World Health
Organization (WHO) suggests that worldwide the global
populationis in the midst of a diabetes epidemicwith people
in Southeast Asia and Western Paciﬁc being mostly at risk.
The number of cases for diabetes that is currently at 171
millionispredicted toreach 366million bythe year2030[1].
Most prevalent form of diabetes is non-insulin depen-
dent diabetes mellitus (NIDDM/type II). The treatment of
type II diabetes is complicated by several factors inherent
to the disease and elevated post prandial hyperglycemia
(PPHG) is one of the risk factors [2]. PPHG is elevated by
the action of glucosidases, a class of enzymes that helps in
the breakdown of complex carbohydrates into simple sugars
such as maltose and glucose. Glucosidase inhibitors such as
α-amylase inhibitors plays a major role in managing PPHG
in diabetic patients. These α-amylase inhibitors inhibit the
action of α-amylase enzyme leading to a reduction in starch
hydrolysis which shows beneﬁcial eﬀects on glycemic index
control in diabetic patients [3]. The known glucosidase
inhibitors which are conventionally used in the management
of diabetes are acarbose and miglitol (a deoxy nojirimycin
derivative) that competitively and reversibly inhibits α-
glucosidase enzyme from intestine as well as pancreas,
however, both these drugs are known to be associated
with gastrointestinal side eﬀects such as abdominal pain,
ﬂatulence and diarrhea in the patients [4, 5]. Therefore, it
becomes necessary to identify the amylase inhibitors from
natural sources having lesser side-eﬀects.
Ayurveda,the traditional Indian herbal medicinal system
practiced for over thousands of years have reports of
antidiabetic plants with no known side eﬀects. Such plants
and their products have been widely prescribed for diabetic
treatment all around the world with less known mechanistic
basis of their functioning. Hence, these natural products
need to be evaluated scientiﬁcally and methodically in order
to check for their properties [6, 7].2 Evidence-Based Complementary and Alternative Medicine
We tested six plants namely Azadirachta indica; Syzy-
gium cumini; Ocimum tenuﬂorum; Murraya koenigii; Linum
usitatissimum traditionally used in Ayurveda along with
Bougainvillea spectabilis usedasahypoglycemicplantinWest
Indies and some parts of Asia. Most of the plants tested in
this study are part of dietary component, so there is less
possibility of side eﬀects caused by these plants. Of the six
plants tested, A. indica and S. cumini are earlier reported
to possess α-amylase inhibitory activity [8]. The extracts
of all these plants were tested for their ability to inhibit
the enzymatic activity of commercially available porcine
pancreatic α-amylase and glucosidases from pancreas, liver
and small intestine of Swiss mice.
2.Materialsand Methods
2.1. Chemicals. DNSA (dinitrosalicylic acid), porcine pan-
creatic α-amylase and chloroform were obtained from
SRL Pvt. Ltd (Mumbai, India). Di-potassium hydrogen
phosphate (K2HPO4), potassium dihydrogen phosphate
(KH2PO4), methanol, sodium potassium tartarate, sodium
hydroxide (NaOH), were obtained from Merck Chemicals
Ltd (Mumbai, India). Sodium chloride (NaCl) was obtained
from HiMedia Laboratories (Mumbai, India). Acarbose was
obtained from Bayer Pharmaceuticals Pvt. Ltd (Mumbai,
India). All the chemicals and reagents procured were of A.R.
grade.
2.2. Plant Materials. Leaves of A. indica, M. koenigii, O.
tenuﬂorum, B. spectabilis and seeds of L. usitatissimum and
S. cumini were collected in and around Pune city in the
months of February, March and June. All the plants were
authenticated by Botanical Survey of India (BSI), Pune,
India.
2.3. Preparation of Plant Extracts. The leaves were washed
and air dried at room temperature. The chloroform,
methanol and aqueous extracts were prepared sequentially
in soxhlet extractor using 30g of dried plant tissue mixed
with 150ml of the respective solvent (100% v/v) for 24h
[9, 10].Methanolic and chloroformextractswere evaporated
todryness inrotary evaporator,whereas theaqueousextracts
were lyophilized[11].25mg dry weight ofeachcrudeextract
was further reconstituted in 2.5 ml of distilled water and
1:20 dilution of all these extracts were used for further
studies.
2.4. Preparation of Murine Pancreatic, Liver and Small
Intestine Extracts. The 10-week-old Swiss male mice were
procured from the animal house of Department of Zoology.
TheentireprocedurewascarriedoutwithguidelinesofInsti-
tutional Animal Ethical Committee. The mouse weighing
27g was starved for 12h. Pancreas; liver and small intestine
tissues were excised and homogenized with 10mM ice cold
phosphate buﬀer containing 100mM NaCl (1:10 dilution;
w/v) and appropriate amount of protease inhibitors. The
homogenate was centrifuged for 10 min at 10 000 r.p.m. and
the supernatant was taken as a source of the enzyme [12].
2.5. α-Amylase Inhibition Assay. The 45.5 μgm l −1 of porcine
pancreatic α-amylase was incubated with 25mgml−1 plant
extracts. One percent starch was used as substrate. The plant
extracts without α-amylase were used as controls and the
test reading were subtracted from the absorbance of these
controls. The reducing sugar was estimated using DNSA
assay at A540 nm and the enzyme units were expressed as
micro molar per minute [13]. One unit of enzyme was
deﬁnedastheamount ofenzyme requiredtoliberate1μMo f
maltose under assay conditions. The ﬁnal inhibition shown
by diﬀerent crude extracts were compared with the standard
inhibitor, 1.9mM acarbose. The 50% inhibition concentra-
tion (IC50) of plant extracts against porcine pancreatic α-
amylase was also calculated.
2.6. Glucosidase Inhibition Assay with Murine Pancreatic,
Liver and Small Intestinal Extracts. Supernatant obtained
from pancreas, liver and small intestine tissues were taken
as a source of enzyme and were diluted so as to get
an absorbance of 0.4 (at 280nm) which corresponds to
11.52, 3.62, and 46.40μg of protein respectively. Protein
was estimated using Bradford standard curve [14]. The
enzyme inhibition assay was carried out as described above.
The 50% inhibition concentration (IC50) of plant extracts
against pancreatic, small intestinal and liver glucosidases was
calculated.
2.7. Statistical Analysis. The statistical analysis was per-
formedusingonewayanalysis ofvariance(ANOVA)andtwo
tailed t-test (P < .05). Results are expressed as means ± SEM
n = 3.
3.Results
3.1. Porcine Pancreatic α-Amylase Inhibitory Activity of Plant
Extracts. Porcine pancreatic α-amylase with 0.21Umin−1
was taken as 100% enzymatic activity. Chloroform extract
of M. koenigii, B. spectabilis, O. tenuﬂorum and S. cumini
showed enzyme inhibition of 56.64, 29.43, 24.57 and 22.31%
respectively (Figure 1). A signiﬁcant inhibition was observed
with extracts of O. tenuﬂorum; whereas A. indica and L.
usitatissimum showed no inhibition with pure porcine α-
amylase. The chloroform extract of M. koenigii showed
signiﬁcant diﬀerence with P < .05 as compared with other
plant extracts (Figure 1).
3.2. Murine Pancreatic Glucosidases Inhibitory Activity of
Plant Extracts. Murine pancreatic tissue weighing 1.2g with
72.0μgml −1 of total protein was used as a source of
enzyme, of which 11.5μg of protein was used for inhibition
assay. Pancreatic enzyme activity exhibiting 0.26Umin−1
was taken as 100% enzymatic activity. Chloroform extracts
of M. koenigii, B. spectabilis and S. cumini showed enzyme
inhibitory activity of 83.94, 51.99 and 43.28% and aqueous
extracts of O. tenuﬂorum, L. usitatissimum and B. spectabilis
showed enzyme inhibitory activity of 76.27, 61.68 and
55.32%, respectively as compared to acarbose which showed
40.43% enzyme inhibition. The plant extracts of A. indicaEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: The percent relative enzyme activity after inhibition with (a) M. koenigii (b) B. spectabilis (c) O. tenuﬂorum (d) S. cumini,e x t r a c t s
on porcine pancreatic α-amylase. Acarbose is taken as standard α-amylase inhibitor. Pure porcine pancreatic α-amylase serves as control.
The data is indicated as the mean ± SEM; (n = 3). Data with diﬀerent asterisks (∗, ∗∗, ∗∗∗) shows signiﬁcant diﬀerence with (∗)d e n o t i n g
more signiﬁcantvalue (P < .05), two-tailed student t-test.
and L. usitatissimum showed negligible enzyme inhibition.
The chloroform extract of O. tenuﬂorum showed signiﬁcant
diﬀerencewithP < .05ascomparedwith otherplantextracts
(Table 1).
3.3. Murine Small Intestinal Glucosidases Inhibitory Activity
of Plant Extracts. Murine small intestine tissue weighing
0.6g with 145μgml −1 total protein was used as a source of
enzyme of which 46.40μg of protein was used for inhibition
assay. Intestinal enzyme activity exhibiting 0.03Umin−1 was
taken as 100% enzymatic activity. Aqueous and methanolic
extracts of A. indica showed enzyme inhibition of 62.44 and
41.07%while M.koenigii chloroformextract showed enzyme
inhibition of 60.99 and 43.72%, respectively, followed by S.
cumini chloroform extracts with 44.40% enzyme inhibition.
However, acarbose failed to show any inhibition with
intestinal glucosidase. The chloroform extract of M. koenigii
showed signiﬁcant diﬀerence with P < .05 as compared with
other plant extracts (Table 2).
3.4. Murine Liver Glucosidases Inhibitory Activity of Plant
Extracts. Murine liver tissue extract weighing 1.8g with
181μgml −1 total protein was used as a source of enzyme, of
which 3.62μg of protein was used for inhibition assay. Liver
enzyme activity exhibiting 0.06Umin−1 was taken as 100%
enzymatic activity. The methanolic extract of S. cumini, A.
Table 1: Percent enzyme inhibition shown by plant extracts with
pancreatic glucosidases.
Acarbose
(40.43 ± 1.22)
% Glucosidases inhibition activity
Methanol Aqueous Chloroform
Murraya koenigii
(L.) Sprengel
ND ND 83.93 ± 1.55∗
Bougainvillea
spectabilis
ND 55.31 ± 5.09 51.98 ± 6.07
Ocimum
tenuiﬂorum (L.)
ND 76.27 ± 3.67∗∗ ND
Syzygium cumini
(L.) Skeels
ND ND 43.28 ± 1.48
Azadirachta indica
Adr. Juss
ND ND ND
Linum
usitatissimum (L.)
26.01 ± 3.18 61.67 ± 2.86∗∗ ND
The table shows percent inhibition of pancreatic glucosidases using plant
extracts. The data is indicated as the mean ± SEM; (n = 3). Two-tailed t-
test was applied. Values with diﬀerent asterisk (∗, ∗∗)s h o w ss i g n i ﬁ c a n t
diﬀerence with (∗) denoting more signiﬁcant value, P < .05, two-tailed
student t-test.ND deﬁnes no enzyme inhibition.
indica and B. spectabilis showed inhibition of 55.09, 52.11
and 33.09% respectively, whereas the aqueous extracts of4 Evidence-Based Complementary and Alternative Medicine
Table 2: Percent enzyme inhibition shown by plant extracts with
small intestinal glucosidases.
Acarbose (ND) % Glucosidases inhibition activity
Methanol Aqueous Chloroform
Murraya koenigii
(L.) Sprengel
43.71 ± 2.42 ND 60.99 ± 3.20∗∗
Bougainvillea
spectabilis
ND ND ND
Ocimum
tenuiﬂorum (L.)
ND ND ND
Syzygium cumini
(L.) Skeels
ND ND 44.37 ± 1.92∗
Azadirachta indica
Adr. Juss
41.7 ± 2.97∗∗ 62.43 ± 3.35∗ ND
Linum
usitatissimum (L.)
ND ND ND
The table shows percent inhibitory activity of small intestinal glucosidases
using plant extracts. The data is indicated as the mean ± SEM; (n = 3).
Two-tailed t-test was applied. Values with diﬀerent asterisks (∗,∗∗)s h o w s
signiﬁcantdiﬀerencewith(∗)denotingmore signiﬁcantvalue,P < .05,two-
tailed student t-test.ND deﬁnes no enzyme inhibition.
Table 3: Percent enzyme inhibition shown by plant extracts with
liver glucosidases.
Acarbose
(95.61 ± 2.36)
(%) Glucosidases inhibition activity
Methanol Aqueous Chloroform
Murraya koenigii
(L.) Sprengel
ND ND ND
Bougainvillea
spectabilis
33.09 ± 3.02 ND ND
Ocimum
tenuiﬂorum (L.)
ND 26.65 ± 3.98 ND
Syzygium cumini
(L.) Skeels
55.08 ± 3.32∗∗ ND ND
Azadirachta indica
Adr. Juss
52.10 ± 3.31∗∗ 69.28 ± 2.59∗ ND
Linum
usitatissimum (L.)
ND ND ND
The table shows percent inhibitory activity of liver glucosidases using plant
extracts. The data is indicated as the mean ± SEM; (n = 3). Two-tailed t-
test was applied. Values with diﬀerent asterisks (∗, ∗∗)s h o w ss i g n i ﬁ c a n t
diﬀerence with (∗) denoting more signiﬁcant value, P < .05, two-tailed
student t-test. ND deﬁnes no enzyme inhibition.
A. indica and O. tenuﬂorum showed enzyme inhibition of
69.29 and 26.63%, respectively. The chloroform extract of
B. spectabilis showed signiﬁcant diﬀerence with P < .05 as
compared with other plant extracts (Table 3).
4.Discussion
There are many reports of herbal extracts being used in
Ayurvedic literature as antidiabetic which are directly or
indirectly used for the preparation of many modern drugs.
However, these plants have not gained much importance
a sm e d i c i n e sa n do n eo ft h ef a c t o r si sl a c ko fs p e c i ﬁ c
standards being prescribed for herbal medicines and sup-
portive animal/clinical trials [15]. In the present study, we
investigate six known plants, namely A. indica; S. cumini; O.
tenuﬂorum; M. koenigii; L. usitatissimum and B. spectabilis
having antidiabetic properties for their possible glucosidase
i n h i b i t o r ya c t i v i t y .P l a n t sa r ek n o w nt op r o d u c eal a r g e
variety of glucosidase inhibitors that provides protection
against insects and microbial pathogens [16, 17] therefore
plantextractswereanalyzedforα-amylase inhibitoryactivity.
Pancreatic and intestinal glucosidases are the key
enzymes of dietary carbohydrate digestion and inhibitors
of these enzymes may be eﬀective in retarding glucose
absorption to suppress PPHG. In diabetic state, excessive
hepatic glycogenolysis and gluconeogenesis is associated
with decreased utilization of glucose by tissues being the
fundamental mechanism underlying hyperglycemia [18].
The liver glucosidase inhibitors, inhibits α-1,6-glucosidase
of glycogen-debranching enzymes in the liver and reduces
the glycogenolytic rate which increases the accumulation
of glycogen stores in the liver [19, 20]. Inhibition of these
enzyme systems decreases the current blood glucose levels in
diabetic patient (as a short term eﬀect) and shows a small
reductioninhemoglobin A1c level(asalongtermeﬀect)[21].
Earlier studies indicated that M. koenigii possess hypo-
glycemicactivity, decreased glycogenolysisand gluconeogen-
esis properties and also ﬁnds itsapplicationas an adjuvant to
dietary therapy and drug treatment for controlling Diabetes
Mellitus [22–24]. Our investigation reported M. koenigii as
a good glucosidases inhibitor showing inhibition against
porcine pancreatic α-amylase as well as murine pancreatic
and intestinal glucosidases. The chloroform extract of M.
koenigii showed signiﬁcant inhibition (IC50 values of 1.96,
1.06 and 2.68μgml −1) with porcine pancreatic α-amylase
(56.40%) as well as murine pancreatic and intestinal glu-
cosidases, respectively, which is signiﬁcantly higher than
acarbose. Interestingly the phenolic content of this extract
was very low, so the inhibitory activity may be because of
speciﬁc inhibitory compounds. Methanolic extract showed
inhibition (IC50 value of 1.96μgml −1) only with murine
intestinal glucosidase as shown in Table 2.
Similarly O. tenuﬂorum shows inhibition of α-amylase
known to possess antidiabetic properties [25, 26]. The three
extracts of O. tenuﬂorum shows inhibitory activity against
porcine α-amylase, murine pancreatic and liver glucosidases.
Chloroform extract possess more potent inhibitory activity
(IC50 value of 1.76μgml −1) with murine pancreatic glu-
cosidases. The inhibitory activity of aqueous extract (IC50
values of 1.55 and 9.86μgml −1)w a so b s e r v e dw i t hp o r c i n e
α-amylase and with murine liver glucosidases, respectively,
which is signiﬁcantly more than acarbose.
Syzygium cumini is known to possess properties of
normoglycemia and lowers blood glucose levels by improv-
ing oral glucose tolerance [27, 28]. Our study suggests
S. cumini as a good inhibitor of glucosidases. Inhibitory
activity of chloroform extract (IC50 values of 4.28, 3.72
and 5.60μgml −1) was observed against porcine α-amylase,
murine pancreatic and murine intestinal glucosidases,
respectively. The methanolic extract of S. cumini showedEvidence-Based Complementary and Alternative Medicine 5
inhibition with only murine liver glucosidases (IC50 =
2.68μgml −1).
Bougainvillea spectabilis on the other hand is being
used for the treatment of diabetes in the islands of West
Indies and Asia. It is claimed to exert insulin-like eﬀects
and contain D-pinitol (3-O-methylchiroinositol) [29–31].
Our studies indicated B. spectabilis chloroform extract has
eﬀective inhibition (IC50 values of 3.20 and 2.06μgml −1)
on porcine pancreatic α-amylase and murine pancreatic
glucosidases. The aqueous extract showed inhibition (IC50
= 11.16μgml −1) with murine pancreatic glucosidases and
methanolic extract (IC50 = 9.26μgml −1) showed inhibition
with murine liver glucosidase. The eﬀects could be possibly
because of the high-phenolic contents present in the crude
extracts.
Azadirachta indica is one of the widely used antidia-
betic plants, which possess hypolipidaemic, hypoglycaemic,
immunostimulant and hepatoprotective properties [32–34].
Aqueous extracts of neem leaves was reported to reduce
blood glucose and this eﬀect could be due to blocking
the action of epinephrine on glycogenolysis and peripheral
utilization of glucose [35]. It is not a glucosidase inhibitor
as evidenced by no signiﬁcant inhibition with porcine
pancreatic α-amylase. However, methanolic (IC50 values of
2.60 and 1.80 μgm l −1)a n da q u e o u se x t r a c t( I C 50 values of
3.17 and 6.21 μgm l −1) showed inhibition with murine liver
andintestinalglucosidases,respectively,whichissigniﬁcantly
more than acarbose.
Linum usitatissimum is known to possess plasma triglyc-
erides and cholesterol lowering properties. This plant being
a dietary component is also known to have hypolipidemic
eﬀect [36]. We investigate its role as glucosidase inhibitor.
The aqueous (IC50 value of 3.21μgml −1) and methanolic
extract (IC50 value of 18.62μgm l −1) has shown inhibition
with murine pancreatic glucosidases which is signiﬁcantly
more than acarbose.
Diabetes being multifactorial disease the treatment
choice diﬀers from patient to patient. Therefore, it is
important to ﬁnd out the biological activity of these herbal
extracts. Theoretically, these glucosidase inhibitors from
plants act through a variety of mechanism. Presently it is not
possible either to pin point the exact mechanism of inhibi-
tion of these extracts or to identify the active principle(s)
responsible for such eﬀect in this study. Nevertheless, the
present study identiﬁes the M. koenigii and O. tenuﬂorum
as good glucosidase inhibitors of pancreatic and intestinal
enzymes. They can be further studied and may be used
as dietary supplement for controlling PPHG in type II
diabetes.
5.Conclusion
M. koenigii and O. tenuﬂorum shows signiﬁcant inhibition
with porcine pancreatic, murine pancreatic as well as intes-
tineglucosidase.Thismayhavebeneﬁcialeﬀectsinmanaging
type II diabetes mellitus and could be used as an indicator
for combinational therapy which can be taken up in further
studies.
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